Christopher Peetz insider trades: Mirum Pharmaceuticals (MIRM) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Christopher reports to the SEC
Open-market buys and sales
25 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | MIRM | ↓ Sell | 20,000 | $90.00 | $1.8M | Direct | Nov 4, 2026 (0d) |
| Sep 1, 2026 | MIRM | ↓ Sell | 30,000 | $98.68 | $3.0M | Direct | Sep 3, 2026 (2d) |
| Aug 10, 2026 | MIRM | ↓ Sell | 20,000 | $98.92 | $2.0M | Direct | Aug 11, 2026 (1d) |
| Jul 6, 2026 | MIRM | ↓ Sell | 20,000 | $122.27 | $2.4M | Direct | Jul 8, 2026 (2d) |
| Jun 1, 2026 | MIRM | ↓ Sell | 30,000 | $95.84 | $2.9M | Direct | Jun 2, 2026 (1d) |
| Mar 16, 2026 | MIRM | ↓ Sell | 40,985 | $91.98 | $3.8M | Direct | Mar 17, 2026 (1d) |
| Feb 2, 2026 | MIRM | ↓ Sell | 9,108 | $103.30 | $941K | Direct | Feb 3, 2026 (1d) |
| Jan 26, 2026 | MIRM | ↓ Sell | 6,831 | $96.19 | $657K | Direct | Jan 27, 2026 (1d) |
| Jan 22, 2026 | MIRM | ↓ Sell | 7,098 | $93.33 | $662K | Direct | Jan 23, 2026 (1d) |
| Aug 11, 2025 | MIRM | ↓ Sell | 40,000 | $62.00 | $2.5M | Direct | Aug 12, 2025 (1d) |
| Aug 7, 2025 | MIRM | ↓ Sell | 40,000 | $55.25 | $2.2M | Direct | Aug 8, 2025 (1d) |
| Mar 17, 2025 | MIRM | ↓ Sell | 27,279 | $44.21 | $1.2M | Direct | Mar 18, 2025 (1d) |
| Mar 3, 2025 | MIRM | ↓ Sell | 40,000 | $46.91 | $1.9M | Direct | Mar 4, 2025 (1d) |
| Feb 3, 2025 | MIRM | ↓ Sell | 9,102 | $48.22 | $439K | Direct | Feb 4, 2025 (1d) |
| Jan 24, 2025 | MIRM | ↓ Sell | 6,837 | $47.92 | $328K | Direct | Jan 27, 2025 (3d) |
| Jan 7, 2025 | MIRM | ↓ Sell | 7,489 | $42.82 | $321K | Direct | Jan 8, 2025 (1d) |
| Feb 2, 2024 | MIRM | ↓ Sell | 6,013 | $26.19 | $157K | Direct | Feb 5, 2024 (3d) |
| Jan 8, 2024 | MIRM | ↓ Sell | 5,209 | $28.03 | $146K | Direct | Jan 9, 2024 (1d) |
| Jul 3, 2023 | MIRM | ↓ Sell | 5,498 | $25.65 | $141K | Direct | Jul 5, 2023 (2d) |
| Jan 9, 2023 | MIRM | ↓ Sell | 5,159 | $20.62 | $106K | Direct | Mar 18, 2024 (434d) |
| Nov 24, 2021 | MIRM | ↑ Buy | 7,000 | $14.40 | $101K | Direct | Nov 29, 2021 (5d) |
| Oct 1, 2021 | MIRM | ↓ Sell | 3,672 | $19.26 | $71K | Direct | Oct 1, 2021 (0d) |
| Sep 23, 2021 | ALPN | ↓ Sell | 1,900 | $10.17 | $19K | Christopher Peetz & Christine Peetz | Sep 24, 2021 (1d) |
| Dec 23, 2020 | MIRM | ↑ Buy | 5,000 | $18.70 | $93K | By The Peetz Family Trust | Dec 28, 2020 (5d) |
| Sep 9, 2019 | MIRM | ↑ Buy | 9,070 | $11.02 | $100K | By The Peetz Family Trust | Sep 10, 2019 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MIRM insiders
Open-market trades in the last 12 months
About Christopher Peetz's insider trades
Christopher Peetz is Chief Executive Officer at Mirum Pharmaceuticals (MIRM). Since Sep 9, 2019, Christopher has reported 3 open-market purchases worth $294K and 22 sales worth $27.6M on SEC Form 4. In the last 12 months: 9 sales ($18.1M).
Their filings also include grants and awards (26 filings), option exercises (16 filings), shares returned to the company (2 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MIRM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.